A comprehensive review on potential therapeutics interventions for COVID-19
COVID-19 is an infectious respiratory disease caused by SARS-CoV-2, a new beta
coronavirus that emerged in Wuhan, China. Being primarily a respiratory disease, it is highly …
coronavirus that emerged in Wuhan, China. Being primarily a respiratory disease, it is highly …
[PDF][PDF] COVID-19 Treatment: The Race Against Time. Electron J Gen Med. 2020; 17 (6): em227
The new outbreak of the novel coronavirus infection emerged in Wuhan-China in late 2019,
by the end of Mar 2020, it has spread in more than 178 countries and territories. There is no …
by the end of Mar 2020, it has spread in more than 178 countries and territories. There is no …
COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials
R Chakraborty, S Parvez - Biochemical pharmacology, 2020 - Elsevier
COVID-19, the greatest public health emergency of the 21st century, has affected 215
countries and territories around the world resulting in 15,151,738 confirmed cases and …
countries and territories around the world resulting in 15,151,738 confirmed cases and …
Repurposing drugs, ongoing vaccine, and new therapeutic development initiatives against COVID-19
As the COVID-19 is still growing throughout the globe, a thorough investigation into the
specific immunopathology of SARS-CoV-2, its interaction with the host immune system and …
specific immunopathology of SARS-CoV-2, its interaction with the host immune system and …
Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus
JC Oliver, EN Silva, LM Soares… - … in Vaccines and …, 2022 - journals.sagepub.com
According to the World Health Organization (WHO), in the second half of 2022, there are
about 606 million confirmed cases of COVID-19 and almost 6,500,000 deaths around the …
about 606 million confirmed cases of COVID-19 and almost 6,500,000 deaths around the …
Drugs for COVID-19: An update
J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
Treatments for COVID-19: Lessons from 2020 and new therapeutic options
F Salasc, T Lahlali, E Laurent, M Rosa-Calatrava… - Current Opinion in …, 2022 - Elsevier
To face the COVID-19 pandemic, prophylactic vaccines have been developed in record
time, but vaccine coverage is still limited, accessibility is not equitable worldwide, and the …
time, but vaccine coverage is still limited, accessibility is not equitable worldwide, and the …
Potential COVID‐19 therapeutic agents and vaccines: an evidence‐based review
Since the early days of 2020, the severe acute respiratory syndrome coronavirus 2
pandemic has become a global health concern. Currently, some therapies and vaccines …
pandemic has become a global health concern. Currently, some therapies and vaccines …
[HTML][HTML] Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
A Awadasseid, Y Wu, Y Tanaka, W Zhang - Biomedicine & …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causal factor of the
coronavirus disease 2019 (COVID-19). Drug repurposing, portraying patented drugs as a …
coronavirus disease 2019 (COVID-19). Drug repurposing, portraying patented drugs as a …
COVID-19: A review of therapeutic strategies and vaccine candidates
The world is engulfed by one of the most widespread and significant public health crises in
decades as COVID-19 has become among the leading causes of death internationally. The …
decades as COVID-19 has become among the leading causes of death internationally. The …